Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19272053 | BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS | July 2025 | January 2026 | Allow | 6 | 0 | 0 | No | No |
| 19182602 | Cosmetic Formulation | April 2025 | August 2025 | Allow | 4 | 1 | 0 | No | No |
| 19170092 | TRIPTOLIDE FORMULATIONS | April 2025 | January 2026 | Allow | 10 | 1 | 1 | No | No |
| 19169843 | USE OF VARENICLINE FOR TREATING OCULAR CONDITIONS | April 2025 | February 2026 | Allow | 10 | 2 | 1 | No | No |
| 19098518 | EXTRACELLULAR MATRIX HYDROGEL MICROSPHERE, AND PREPARATION METHOD AND APPLICATION THEREOF | April 2025 | August 2025 | Allow | 5 | 0 | 1 | No | No |
| 19077514 | COMPOSITION FOR HAIR PROTECTION OR HAIR STRENGTHENING | March 2025 | August 2025 | Allow | 5 | 1 | 0 | No | No |
| 19037073 | ORGANIC DENTAL GUM AND METHOD OF FABRICATING THE DENTAL GUM | January 2025 | August 2025 | Allow | 6 | 0 | 1 | No | No |
| 18971812 | TREATED OSSEOUS PARTICULATE FLUFF COMPOSITION | December 2024 | August 2025 | Abandon | 8 | 1 | 0 | No | No |
| 18960204 | MINERAL COMPONENT EXTRACT FROM BORYEONG MUD, METHOD FOR EXTRACTING THE SAME, AND COSMETIC COMPOSITION CONTAINING BORYEONG MUD MINERAL EXTRACT | November 2024 | August 2025 | Allow | 9 | 1 | 1 | No | No |
| 18957812 | ECO-FRIENDLY AND BIOCOMPATIBLE HYBRID NANOMATERIALS IN SUNSCREEN | November 2024 | August 2025 | Allow | 9 | 1 | 1 | Yes | No |
| 18953754 | SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS | November 2024 | March 2026 | Abandon | 16 | 2 | 1 | No | No |
| 18934892 | USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS | November 2024 | July 2025 | Allow | 9 | 1 | 0 | No | No |
| 18896954 | 3D PRINTED BONE DEFECT REPAIR SCAFFOLD LOADED WITH EXTRACELLULAR MATRIX OF MESENCHYMAL STEM CELLS AND PREPARATION METHOD THEREOF | September 2024 | May 2025 | Abandon | 8 | 1 | 0 | No | No |
| 18895498 | PHARMACEUTICAL COMPOSITIONS OF CABOTEGRAVIR | September 2024 | September 2025 | Abandon | 12 | 2 | 1 | No | No |
| 18822564 | Dry Powdered Formulations | September 2024 | August 2025 | Abandon | 11 | 1 | 1 | No | No |
| 18841788 | DOUBLE-CROSSLINKED FIBRIN GEL, RAW MATERIAL COMPOSITION AND KIT THEREOF, AND APPLICATION THEREOF | August 2024 | June 2025 | Allow | 9 | 1 | 0 | No | No |
| 18811158 | METHODS FOR FIXING HAIR AND SKIN | August 2024 | November 2024 | Allow | 3 | 1 | 0 | No | No |
| 18775629 | AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | July 2024 | January 2026 | Abandon | 18 | 2 | 1 | No | Yes |
| 18766716 | METHOD FOR TREATING CANCER CELLS WITH A CU/AG PARTICLE COMPOSITION | July 2024 | September 2024 | Allow | 2 | 0 | 0 | Yes | No |
| 18763376 | Use of an arsenic compound for treating a short or long cytokine storm in various autoimmune/inflammatory diseases in humans or animals | July 2024 | October 2025 | Abandon | 15 | 2 | 0 | No | No |
| 18669051 | COMPOSITIONS AND METHODS FOR SUNLESS TANNING | May 2024 | July 2024 | Abandon | 2 | 0 | 0 | No | No |
| 18659750 | TRANSDERMAL CANNABIDIOL DELIVERY DEVICE | May 2024 | April 2025 | Allow | 11 | 2 | 1 | Yes | No |
| 18643595 | TOPICAL PHARMACEUTICAL COMPOSITIONS | April 2024 | August 2024 | Allow | 4 | 1 | 0 | No | No |
| 18639137 | ADHESIVE MEDICAL PRODUCTS AND METHODS FOR TREATING GASTROINTESTINAL LESIONS | April 2024 | March 2026 | Abandon | 23 | 2 | 0 | Yes | No |
| 18631545 | MODIFIED RELEASE COMPOSITION OF ORLISTAT AND ACARBOSE FOR THE TREATMENT OF OBESITY AND RELATED METABOLIC DISORDERS | April 2024 | October 2025 | Allow | 18 | 2 | 1 | Yes | No |
| 18624746 | BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS | April 2024 | September 2024 | Allow | 5 | 1 | 0 | No | No |
| 18625137 | Methods of treating or reducing symptoms of stimulant dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and glutamate allosteric modulators | April 2024 | January 2026 | Abandon | 21 | 1 | 1 | No | No |
| 18625131 | Methods of treating or reducing symptoms of anxiety, depression, attention deficiency (ADD), attention deficient hyperactivity (ADHD), obsessive compulsive (OCD), Bipolar disorder, and related disorders/conditions via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and other allosteric modulators. | April 2024 | December 2025 | Abandon | 21 | 1 | 1 | No | No |
| 18625181 | Methods of treating or reducing symptoms of opiate dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and opiate allosteric modulators | April 2024 | March 2026 | Abandon | 23 | 1 | 1 | No | No |
| 18616121 | Methods of treating or reducing symptoms of nicotine dependency (addiction) such as tobacco-use (smoking, vaping, sublingual, oral) and/or tobacco smoking cessation via combination therapy with allosteric modulators and phenethylamines. | March 2024 | September 2025 | Abandon | 18 | 2 | 1 | No | No |
| 18616089 | Methods of treating or reducing symptoms of brain cancer such as glioma and glioblastoma via combination therapy with allosteric modulators and phenethylamines. | March 2024 | June 2025 | Abandon | 15 | 2 | 1 | No | No |
| 18607763 | FISH-DERIVED PEPTIDOGLYCAN RECOGNITION PROTEIN MUTANTAND APPLICATION THEREOF | March 2024 | August 2024 | Allow | 5 | 1 | 0 | No | No |
| 18606551 | CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING STABILIZERS OF LABILE COMPONENTS SUCH AS DRUGS | March 2024 | August 2024 | Allow | 5 | 0 | 1 | No | No |
| 18606678 | PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF | March 2024 | September 2025 | Allow | 18 | 2 | 1 | No | No |
| 18602710 | MULTISTAGE CALCINATION METHOD FOR MAKING HOLLOW SILICA SPHERES | March 2024 | August 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18599582 | METHOD FOR DECREASING COLORECTAL CANCER CELLS | March 2024 | June 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18685970 | CRYSTALLINE FORMS OF METHYL 2-[2-[2-BROMO-4-FLUORO-5-[3-METHYL-2,6-DIOXO-4-(TRIFLUOROMETHYL)PYRIMIDIN-1-YL]PHENOXY]PHENOXY]-2-METHOXY-ACETATE | February 2024 | February 2026 | Abandon | 23 | 0 | 0 | No | No |
| 18586253 | BODY INK COMPOSITIONS AND APPLICATORS | February 2024 | July 2025 | Allow | 16 | 3 | 1 | No | No |
| 18583657 | METHODS FOR RAISING NITRIC OXIDE AND REDUCTION OF URIC ACID | February 2024 | March 2025 | Abandon | 13 | 2 | 0 | No | No |
| 18437042 | WATER-BASED NAIL POLISH | February 2024 | December 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18435068 | SOLANUM LYCOPERSICUM SEED OIL FREEZE-DRIED POWDER WITH WHITENING EFFICACY, COMPOSITION, AND PREPARATION METHOD AND APPLICATION THEREOF | February 2024 | June 2025 | Allow | 16 | 2 | 1 | No | No |
| 18432437 | POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION | February 2024 | May 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18430750 | METHOD AND COMPOSITION FOR LOWERING TOTAL SYSTEMIC CHOLESTROL, LDL CHOLESTEROL, AND NON-HDL CHOLESTEROL | February 2024 | February 2026 | Abandon | 25 | 4 | 1 | Yes | No |
| 18431324 | Polymer Coatings Containing Drug Powder Of Controlled Morphology | February 2024 | October 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18428005 | COMPLEXES OF WHEY PROTEIN MICELLES AND PECTIN AND BODY MUSCLE PROTEIN SYNTHESIS | January 2024 | March 2026 | Abandon | 25 | 2 | 0 | No | Yes |
| 18423908 | DRY EYE TREATMENTS | January 2024 | August 2025 | Abandon | 18 | 0 | 1 | No | No |
| 18417229 | CROSSLINKED ORGANOSILICON RESIN, A METHOD FOR PRODUCING SAME, AND A COSMETIC | January 2024 | February 2026 | Allow | 25 | 0 | 0 | No | No |
| 18418010 | TREATMENT OF DEPRESSION | January 2024 | July 2025 | Abandon | 18 | 2 | 0 | No | No |
| 18414445 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | January 2024 | March 2024 | Allow | 2 | 0 | 0 | No | No |
| 18414442 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | January 2024 | May 2024 | Allow | 4 | 0 | 1 | No | No |
| 18410155 | EVA SEGMENTED INTRAVAGINAL RINGS CONTAINING PROGESTERONE | January 2024 | December 2025 | Abandon | 24 | 2 | 0 | No | No |
| 18402953 | ULTRAHIGH DUCTILITY, NOVEL Mg-Li BASED ALLOYS FOR BIOMEDICAL APPLICATIONS | January 2024 | December 2025 | Allow | 23 | 1 | 0 | No | No |
| 18400069 | PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOF | December 2023 | December 2025 | Allow | 24 | 2 | 0 | No | No |
| 18392013 | COMPOSITIONS, DEVICES, AND METHODS FOR THE TREATMENT OF OVERDOSE AND REWARD-BASED DISORDERS | December 2023 | December 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18392008 | COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDER | December 2023 | December 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18545415 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NEUROTROPHIC AND NEUROPROTECTIVE COMPOSITIONS | December 2023 | April 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18543203 | ENHANCED FORMULATIONS, COMPOSITIONS AND METHODS FOR PEST CONTROL | December 2023 | September 2025 | Allow | 21 | 3 | 1 | No | No |
| 18542059 | BONE REGENERATION MATERIAL HAVING A COTTON-WOOL LIKE STRUCTURE FORMED OF A PLURALITY OF ELECTROSPUN FIBERS | December 2023 | February 2025 | Abandon | 14 | 1 | 1 | No | No |
| 18541054 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | December 2023 | February 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18541570 | INTRAOCULAR PRESSURE REDUCTION WITH INTRACAMERAL BIMATOPROST IMPLANTS | December 2023 | December 2025 | Abandon | 24 | 0 | 1 | No | No |
| 18541995 | LONG-TERM STABLE LIVE FECAL MICROBIOTA COMPOSITION | December 2023 | August 2025 | Allow | 20 | 2 | 1 | Yes | No |
| 18532876 | METHOD FOR ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REGARDLESS OF BODY MASS INDEX | December 2023 | November 2025 | Allow | 24 | 2 | 0 | No | No |
| 18527884 | USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS | December 2023 | March 2025 | Allow | 15 | 1 | 0 | No | No |
| 18525495 | SOLID HAND AND BODY LOTION PELLETS | November 2023 | August 2024 | Abandon | 8 | 1 | 0 | No | No |
| 18515201 | METHOD FOR PREPARING POLY(THIOCTIC ACID)-COPPER COATING ON SURFACE OF CARDIOVASCULAR STENT MATERIAL | November 2023 | November 2025 | Allow | 23 | 0 | 0 | No | No |
| 18511042 | COMPOSITIONS AND METHODS FOR TREATING ANEMIA | November 2023 | October 2025 | Allow | 23 | 2 | 0 | No | No |
| 18506493 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | November 2023 | June 2024 | Allow | 7 | 1 | 0 | No | No |
| 18504280 | AQUEOUS ORAL COMPOSITIONS INCLUDING POTASSIUM CHLORIDE | November 2023 | December 2025 | Allow | 25 | 3 | 0 | No | No |
| 18503232 | Combination and Uses and Treatments Thereof | November 2023 | April 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18386758 | METHOD OF TREATING A GLAZED CERAMIC ARTICLE | November 2023 | April 2025 | Allow | 18 | 0 | 0 | No | No |
| 18500167 | PLASMONIC ENHANCED MAGNETIC NANOPARTICLES HYPERTHERMIA | November 2023 | October 2025 | Abandon | 24 | 2 | 1 | No | No |
| 18386411 | ETHYL 2-[9-(6-FLOURO-2-HYDROXYQUINOLIN-3-YL)-1,8-DIOXO-3,4,9,10-TETRAHYDROACRIDINE-10-YL]-ACETATE AS AN ANTIMICROBIAL COMPOUND | November 2023 | February 2024 | Allow | 3 | 0 | 0 | No | No |
| 18492136 | MATERIALS AND METHODS FOR THE CONTROL OF NEMATODES | October 2023 | July 2025 | Allow | 21 | 1 | 1 | No | No |
| 18382887 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | October 2023 | March 2024 | Allow | 5 | 1 | 1 | No | No |
| 18492284 | DISINTEGRATING MONOLITHIC MODIFIED RELEASE TABLETS CONTAINING QUADRI-LAYER EXTENDED RELEASE GRANULES | October 2023 | July 2025 | Abandon | 21 | 1 | 1 | No | No |
| 18381436 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | October 2023 | December 2025 | Allow | 26 | 1 | 0 | No | No |
| 18286914 | NANOPARTICULATE COMPOSITIONS | October 2023 | October 2025 | Allow | 24 | 0 | 0 | Yes | No |
| 18379598 | Botanical Film-Forming Acne Compositions | October 2023 | June 2025 | Allow | 20 | 1 | 0 | No | No |
| 18555193 | USE IN AN AQUEOUS-ALCOHOLIC COMPOSITION OF POLYMERS OBTAINED BY LOW-CONCENTRATION INVERSE EMULSION POLYMERISATION WITH LOW NEUTRALISED MONOMER LEVEL | October 2023 | November 2024 | Abandon | 14 | 1 | 1 | No | No |
| 18483098 | FREEZE-DRIED ARIPIPRAZOLE FORMULATION | October 2023 | January 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18477212 | METHOD FOR SKIN PROTECTION BY USING A ZnO/NSP COMPOSITE | September 2023 | October 2025 | Allow | 25 | 0 | 0 | No | No |
| 18374334 | HOLLOW SILICA SPHERES WITH NESTED IRON OXIDE PARTICLES | September 2023 | February 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18475634 | SURFACE ZWITTERIONIZED SILICONE ANTIFOULING COATING AND PREPARATION METHOD THEREOF | September 2023 | March 2025 | Abandon | 17 | 2 | 1 | No | No |
| 18370106 | INTERPENETRATING POLYMER NETWORK HYDROGEL | September 2023 | October 2025 | Abandon | 25 | 1 | 1 | No | No |
| 18282406 | COSMETIC COMPOSITION | September 2023 | March 2026 | Abandon | 30 | 0 | 1 | No | No |
| 18465918 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | September 2023 | August 2024 | Abandon | 11 | 1 | 1 | No | No |
| 18463029 | Hair Care Product and Kit | September 2023 | February 2026 | Abandon | 29 | 0 | 1 | No | No |
| 18242099 | Micronutrient composition to improve men health | September 2023 | March 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18548700 | GADUSOL AND GADUSPORINE COMPOUND FORMULATIONS FOR TOPICALS | September 2023 | August 2025 | Abandon | 24 | 3 | 1 | No | No |
| 18240438 | COMPOSITION COMPRISING A COMBINATION CONSISTING OF MAGNOLOL AND HONOKIOL, USE OF THE COMPOSITION, METHOD OF MANUFACTURING THE COMPOSITION, AND COSMETIC PRODUCTS COMPRISING THE COMPOSITION AND METHOD OF MANUFACTURING THEREOF | August 2023 | February 2026 | Allow | 30 | 1 | 1 | Yes | No |
| 18457668 | SILICONE INFUSED WITH SILVER | August 2023 | August 2025 | Abandon | 23 | 1 | 1 | No | No |
| 18456758 | METHODS FOR MAINTAINING CONCENTRATIONS OF VOLATILE LIPOPHILIC COMPOUNDS IN MANUFACTURE OF COMPOSITIONS AND DOSAGE FORMS | August 2023 | January 2026 | Abandon | 29 | 4 | 1 | No | No |
| 18239045 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | August 2023 | February 2026 | Allow | 29 | 2 | 1 | No | Yes |
| 18456072 | WHITE PIGMENT FOR COSMETICS, AND COSMETIC | August 2023 | November 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18236612 | BIO-BASED MOISTURE ABSORPTION AND SWEAT DISCHARGING MULTIFUNCTIONAL FINISHING AGENT AND PREPARATION METHOD AND APPLICATION THEREOF | August 2023 | February 2024 | Allow | 6 | 0 | 1 | No | No |
| 18236278 | COMPOSITION FOR PREVENTING ADHESION OF AIR-BORNE FINE PARTICLES | August 2023 | April 2025 | Abandon | 20 | 1 | 0 | No | No |
| 18233535 | MULTIPLE USE WOUND AND HEALING CREAM | August 2023 | March 2026 | Abandon | 31 | 0 | 1 | No | No |
| 18449358 | GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF | August 2023 | September 2025 | Abandon | 25 | 1 | 1 | No | No |
| 18448259 | BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS | August 2023 | April 2024 | Allow | 8 | 1 | 1 | No | No |
| 18448250 | BIOLOGIC MATRIX FOR A WOUND SITE AND RELATED METHODS | August 2023 | July 2025 | Allow | 23 | 4 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1619.
With a 24.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 17.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Art Unit 1619 is part of Group 1610 in Technology Center 1600. This art unit has examined 8,656 patent applications in our dataset, with an overall allowance rate of 36.6%. Applications typically reach final disposition in approximately 40 months.
Art Unit 1619's allowance rate of 36.6% places it in the 2% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.
Applications in Art Unit 1619 receive an average of 2.78 office actions before reaching final disposition (in the 93% percentile). The median prosecution time is 40 months (in the 13% percentile).
When prosecuting applications in this art unit, consider the following:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.